IRVINE, CA, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is very pleased to report the Company's groundbreaking laboratory research with Dana-Farber Cancer Institute using Nanoparticle ...
read more here
Delivered by @can_nab_is
No comments:
Post a Comment